Literature DB >> 2163536

Characterization of plasmids and plasmid-borne macrolide resistance from Lactobacillus sp. strain 100-33.

L A Rinckel1, D C Savage.   

Abstract

Lactobacillus sp. strain 100-33 is resistant to macrolides, lincosamides, and streptogramin B-type antibiotics (MLSR) and appears to contain several major and minor plasmids. One of these plasmids, pLAR33, is approximately 18 kbp in size. When cells of strain 100-33 were protoplasted and regenerated, an MLSS isolate was derived. The derivative, designated strain ES1, contained a unique plasmid complement in which it had apparently lost the major plasmids of the parental strain, including pLAR33, and retained only a minor plasmid seen in low concentrations in strain 100-33. The MLSR determinant was cloned from plasmid DNA of strain 100-33 on a 3-kbp EcoRV fragment into pBR322 and localized to pLAR33. The determinant expressed macrolide and lincosamide resistance in Escherichia coli HB101, was localized to approximately 1 kbp on the cloned sequence, and is apparently under the control of its own promoter. MLSR electroporants were derived from strain ES1 electroporated with plasmid DNA from strain 100-33; these MLSR isolates had acquired a plasmid complement similar to that of strain 100-33, including pLAR33. Endonuclease digestion and Southern analysis of plasmid DNA from both strains indicated that the major plasmids are multimeric and deleted forms of one archetypal extrachromosomal element.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2163536     DOI: 10.1016/0147-619x(90)90030-g

Source DB:  PubMed          Journal:  Plasmid        ISSN: 0147-619X            Impact factor:   3.466


  6 in total

Review 1.  Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification.

Authors:  R Leclercq; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

2.  Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients.

Authors:  K Hultén; A Gibreel; O Sköld; L Engstrand
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

3.  In vitro activities of ketolide HMR3647, macrolides, and other antibiotics against Lactobacillus, Leuconostoc, and Pediococcus isolates.

Authors:  M Zarazaga; Y Sáenz; A Portillo; C Tenorio; F Ruiz-Larrea; R Del Campo; F Baquero; C Torres
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

4.  Characterization of tetracycline and erythromycin resistance determinants in Treponema denticola.

Authors:  M C Roberts; W O Chung; D E Roe
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

5.  A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes.

Authors:  H Seppälä; M Skurnik; H Soini; M C Roberts; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

6.  Molecular characterization of tet(M) genes in Lactobacillus isolates from different types of fermented dry sausage.

Authors:  Dirk Gevers; Morten Danielsen; Geert Huys; Jean Swings
Journal:  Appl Environ Microbiol       Date:  2003-02       Impact factor: 4.792

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.